World Health Organization. (2019). International Classification of Diseases, 10th Revision (ICD-10). Geneva: WHO.
[2]
American College of Obstetricians and Gynecologists. (2020). Screening for Fetal Chromosomal Abnormalities. ACOG Practice Bulletin No. 226.
[3]
Benn, P., Borell, A., Chiu, R., et al. (2013). Position statement on non-invasive prenatal screening for aneuploidy. Genetics in Medicine, 15(5), 351-352.
[4]
Malone, F. D., Canick, J. A., Ball, R. H., et al. (2005). First-trimester or second-trimester screening, or both, for Down's syndrome. New England Journal of Medicine, 353(19), 2001-2011.
[5]
Norton, M. E., Brar, H., Weiss, J., et al. (2012). Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. American Journal of Obstetrics & Gynecology, 207(2), 137.e1-137.e8.